MAP
ABBV icon

Moody Aldrich Partners’s AbbVie ABBV Stock Holding History

Moody Aldrich Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,946
Closed -$423K – 177
2026
Q1 		$423K Buy
1,946
+26
+1% +$5.77K 0.08% 142
2025
Q4 		$439K Sell
1,920
-34
-2% -$7.75K 0.08% 140
2025
Q3 		$453K Sell
1,954
-626
-24% -$127K 0.09% 134
2025
Q2 		$479K Sell
2,580
-523
-17% -$97.2K 0.09% 128
2025
Q1 		$650K Buy
3,103
+103
+3% +$20K 0.14% 116
2024
Q4 		$533K Buy
3,000
+92
+3% +$16.9K 0.1% 129
2024
Q3 		$574K Sell
2,908
-228
-7% -$42.6K 0.1% 120
2024
Q2 		$538K Sell
3,136
-6,711
-68% -$1.11M 0.1% 126
2024
Q1 		$1.79M Buy
9,847
+321
+3% +$55.3K 0.31% 105
2023
Q4 		$1.48M Sell
9,526
-112
-1% -$16.3K 0.27% 106
2023
Q3 		$1.44M Buy
+9,638
New +$1.41M 0.27% 100

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Moody Aldrich Partners's ABBV Position: Q2 2026 in Review

Moody Aldrich Partners sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 1,946 shares — an estimated $423K sold.

Moody Aldrich Partners first reported a position in ABBV in Q3 2023 and held it in 11 quarters. The position peaked at $1.79M in Q1 2024. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Moody Aldrich Partners reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
  • Moody Aldrich Partners sold 1,946 AbbVie shares in Q2 2026, an estimated $423K.
  • Moody Aldrich Partners first reported a position in AbbVie in Q3 2023 and held it in 11 quarters.
  • Moody Aldrich Partners's AbbVie position peaked at $1.79M in Q1 2024.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Moody Aldrich Partners's 13F filing for Q2 2026, filed 15 Jul 2026.